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Abstract
Background: The number of mobile health apps (MHAs), which are developed to promote healthy behaviors, prevent disease
onset, manage and cure diseases, or assist with rehabilitation measures, has exploded. App store star ratings and descriptions
usually provide insufficient or even false information about app quality, although they are popular among end users. A rigorous
systematic approach to establish and evaluate the quality of MHAs is urgently needed. The Mobile App Rating Scale (MARS)
is an assessment tool that facilitates the objective and systematic evaluation of the quality of MHAs. However, a German MARS
is currently not available.
Objective: The aim of this study was to translate and validate a German version of the MARS (MARS-G).
Methods: The original 19-item MARS was forward and backward translated twice, and the MARS-G was created. App description
items were extended, and 104 MHAs were rated twice by eight independent bilingual researchers, using the MARS-G and MARS.
The internal consistency, validity, and reliability of both scales were assessed. Mokken scale analysis was used to investigate the
scalability of the overall scores.
Results: The retranslated scale showed excellent alignment with the original MARS. Additionally, the properties of the MARS-G
were comparable to those of the original MARS. The internal consistency was good for all subscales (ie, omega ranged from
0.72 to 0.91). The correlation coefficients (r) between the dimensions of the MARS-G and MARS ranged from 0.93 to 0.98. The
scalability of the MARS (H=0.50) and MARS-G (H=0.48) were good.
Conclusions: The MARS-G is a reliable and valid tool for experts and stakeholders to assess the quality of health apps in
German-speaking populations. The overall score is a reliable quality indicator. However, further studies are needed to assess the
factorial structure of the MARS and MARS-G.
(JMIR Mhealth Uhealth 2020;8(3):e14479)  doi: 10.2196/14479
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Introduction
Mobile phones are an integral part of modern life. In Europe,
67% of the population owns smartphones, and the number of
smartphone users is rising worldwide [1]. It has been reported
that 30% of Germans have 11 to 20 apps installed on their
smartphones [2]. The use of mobile apps to improve mental
health and well-being is becoming increasingly common, with
roughly 29% of Germans currently using at least one health app
[3].
Globally, between 95 million and 130 million people speak
German, making it the 11th most spoken language worldwide
[4,5]. Elderly individuals and people with basic education are
commonly monolingual in Germany [6]. Yet, these populations
have a high need for assistance in developing and maintaining
health behaviors and could benefit from the use of mobile health
apps (MHAs). A German MHA rating scale could help
researchers and health care providers assess the quality of health
apps quickly and reliably in their mother tongue. Furthermore,
it would be easy to rate a German app with a German scale.
MHAs offer unique and diverse possibilities for health
promotion. They allow ecological momentary assessments [7,8]
and interventions [8,9]. Additionally, they can be used
irrespectively of geographical, financial, and social conditions;
can simultaneously target nonclinical and clinical populations;
and have the capacity to provide diverse health-management
strategies in an ecological setting [10]. Moreover, they support
individuals, including those from high-need high-cost
populations (eg, those with chronic or lifestyle diseases), in
managing their health [9]; reduce help-seeking barriers; and
offer a wide range of engagement options [10].
Despite the recent proliferation of MHAs [11], there are no
universally accepted criteria for measuring and reporting their
quality [8,12]. Therefore, it is necessary to support researchers,
users, and health care providers (eg, physicians,
psychotherapists, and physiotherapists) in selecting high-quality
MHAs. Safe and reliable use of MHAs requires evidence of
efficacy and quality, information about data protection,
information about routines for emergencies (eg, self-harm and
adverse effects), and overall consideration of associated risks
[10].
Boudreaux and colleagues [13] suggested the following seven
strategies to evaluate MHA quality: (1) Review the scientific
literature; (2) Search app clearinghouse websites; (3) Search
app stores; (4) Review app descriptions, user ratings, and user
reviews; (5) Conduct a social media query within professional
and, if available, patient networks; (6) Pilot the apps; and (7)
Elicit feedback from users. This process might be too demanding
for health care providers and end users when making treatment
choices. A standardized and reliable quality assessment tool
could facilitate this process.
Several MHA evaluation scales exist to date. The American
Psychological Association released an app evaluation model
comprising 33 items across the following five scales:
background information, risk/privacy and security, evidence,
ease of use, and interoperability [12]. The main aim of this
model is to assess the likelihood of harm [9]. However, the
validity and reliability assessment of this rating instrument has
not yet been reported, and there is no agreement regarding its
application [14].
Baumel and colleagues [15] developed the Evaluation Tool for
Mobile and Web-Based eHealth Interventions (ENLIGHT),
according to a comprehensive systematic review of relevant
criteria. The tool allows the evaluation of app quality in terms
of seven dimensions (usability, visual design, user engagement,
content, therapeutic persuasiveness, therapeutic alliance, and
general subjective evaluation) with 28 items. ENLIGHT also
provides a checklist to assess credibility, evidence base, privacy
explanation, and basic security.
The Mobile App Rating Scale (MARS) [16] is the most
commonly used app evaluation tool that allows electronic health
experts to rate MHAs. It includes 19 items comprising four
subscales on objective MHA characteristics (engagement,
functionality, esthetics, and information quality) and a further
10 items comprising two subscales on subjective characteristics
(subjective app quality and perceived impact). The subscale and
overall scores indicate the quality of MHAs. The MARS has
been used to scientifically assess app quality in the following
fields: weight management, physical activity, heart failure, diet
in children and adolescents, medication adherence, mindfulness,
back pain, chronic pain, smoking cessation, and depression
[8,17-24]. Thus, it is the most widely used MHA quality rating
tool in the scientific community. Furthermore, numerous
international efforts promoting safe MHA use (eg, Mobile
Health App Database, PsyberGuide or App Script, Reachout,
Kinds Helpline, Health Navigator, and Vic Health) are based
on the MARS.
The original version of the MARS is in English, but culture-
and language-specific app ratings are needed globally. Spanish
and Italian versions of the MARS have been developed [25,26].
A German MARS is necessary considering the growing and
unregulated MHA market in Germany. Therefore, this study
aimed to develop and validate a German version of the Mobile
App Rating Scale (MARS-G) and to investigate the scalability
of the overall MARS score with Mokken scale analysis—an
approach that is closely related to item response theory.
Methods
Adaptation and Translation
The MARS was translated from English into German by two
independent bilingual scientists (EMM and TP). After review
and discussion of both forward translations, a pilot version of
the MARS-G was created. This pilot version underwent blind
back translation by two bilingual speakers with different
backgrounds (a postdoctoral psychologist [AB] and a
nonacademic individual [LMZ]). Thereafter, the back translation
was compared with the original English version by the bilingual
scientists (EMM and TP), and the penultimate version of the
MARS-G was created. This version was evaluated for
comprehensibility by three researchers and three nonacademics.
After addressing their comments, the final version of the
MARS-G was created and used in this study. The MARS-G can
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be downloaded from the supplementary materials or obtained
from the authors on request.
Search and Procedure
The MARS-G was validated within the framework of a study
on the quality of apps targeting anxiety (E M Messner et al,
unpublished data, 2020). Apps were identified using the
following search terms: anxiety, fears, anxiety attack, anxious,
anxiousness, anxiety disorder, fear, dread, fearful, panic, panic
attacks, worry, and worries. Each search term was provided
separately, as no truncation or use of logic operators (AND,
OR, and NOT) was possible in the Google Play Store and iOS
Store.
The inclusion process was divided into three steps (searching,
screening, and determining eligibility). (1) Using the search
terms mentioned above, the initial app pool was identified. (2)
App details on the store sites were screened, and apps were
downloaded and reviewed if they were developed for anxiety,
were available in German or English, were downloadable
through the official Google Play Store or iOS Store, and met
no relevant exclusion criteria (app bundles [many applications
only available as a group]). (3) All downloaded apps were
assessed and excluded if they did not address anxiety, were not
in German or English, were malfunctioning, or met relevant
exclusion criteria (device incompatibility and development/test
phase). We identified 3562 MHAs from the app stores.
However, we excluded 810 duplicate apps, 2577 apps considered
inappropriate on screening, and 71 apps considered ineligible.
The remaining 104 apps were rated using the MARS and
MARS-G by two independent trained raters. The raters tested
all MHAs for 15 minutes. Quality was assessed immediately
after the testing period in both languages. The assessment of
the MARS-G is present in a review evaluating the quality of
MHAs available for anxiety (E M Messner et al, unpublished
data, 2020).
Rater Training
We followed the rating methodology in the original study by
Stoyanov and colleagues [16]. We created a YouTube video
with an introduction on MARS-G rating and an exercise on how
to rate an app used as an exemplary health app
(TrackYourTinnitus) [27]. This video can be requested from
the corresponding author. Each rater was trained using this
video, and five predefined apps were then rated to ensure that
each rater was appropriately trained. If the individual rating
score was different from our standard rating score by at least 2
points, the difference was discussed until agreement. All raters
had at least a bachelor’s degree in psychology to ensure a
necessary minimum psychodiagnostic competence standard.
German Version of the Mobile Application Rating
Scale
We added the following items in the app description section for
the MARS-G: theoretical background (cognitive-behavioral,
therapy, systemic therapy, etc), methods (eye movement
desensitization and reprocessing, tracking, feedback, etc),
category in the app store (lifestyle, medicine, etc), embedding
into routine care (communication with therapist, etc), type of
use (prevention, treatment, rehabilitation, etc), guidance
(stand-alone, blended care, etc), certification (medical device
law, etc), and data safety (log in, informed consent, etc). The
four sections of the original MARS were expanded with an
additional section focusing on the therapeutic gain associated
with the app. The derived items were as follows: gain for the
patient; gain for the therapist; risks and adverse effects; and
ease of implementation in routine health care.
Analyses
Intraclass Correlation
The included MHAs were rated independently by two trained
raters. The intraclass correlation coefficient (ICC) was calculated
to assess the extent of agreement between the raters. An ICC
of <0.50 indicated poor correlation, 0.51-0.75 indicated
moderate correlation, 0.76-0.89 indicated good correlation, and
>0.90 indicated excellent correlation [28]. According to the
findings of previous studies, an ICC >0.75 was considered to
indicate sufficient correlation [8,29,30].
Internal Consistency
Internal consistency of the MARS-G and its subscales was
assessed as a measure of scale reliability, similar to the original
MARS [16]. Omega was used instead of the widely adopted
Cronbach alpha to assess reliability, as it provides a more
unbiased estimation of reliability [31-33]. For estimations, the
procedure introduced by Zhang and Yuan [34] was used to
obtain robust coefficients and bootstrapped bias-corrected
confidence intervals. Reliability of ω <0.50 indicated
unacceptable internal consistency, 0.51-0.59 indicated poor
consistency, 0.60-0.69 indicated questionable consistency,
0.70-0.79 indicated acceptable consistency, 0.80-0.89 indicated
good consistency, and >0.90 indicated excellent consistency
[35].
Validity
We assessed correlations between corresponding subscales of
the MARS and MARS-G, as well as the overall correlation
between the MARS total score and MARS-G total score. A r
value >0.8 was a priori considered by the author group as an
indicator of a strong and sufficient association between the
MARS and MARS-G. Additionally, mean comparisons were
performed between the dimensions of the MARS and MARS-G,
using two-sided t tests. For all comparisons, a P value <.05 was
considered significant.
Mokken Scale Analysis
Mokken scale analysis (MSA) is a scaling approach closely
related to nonparametric item response theory [36]. The
preconditions to use MSA are monotonicity and nonintersection.
The key parameter in the MSA is Loevinger H. Hi is the scaling
parameter for item i, and the overall scalability of all items
clustering onto scale k is Hk. Hi indicates the strength of the
relationship between a latent variable (app quality) and item i.
A high scalability score indicates a high probability that an
increase in item i is accompanied by an increase in the latent
variable. A scale is considered weak if H is <0.4, moderate if
H is ≥0.4 but <0.49, and strong if H is >0.5 [36]. This approach
has been described in detail previously [36-39]. For both the
MARS and MARS-G, the MSA was conducted to assess the
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scalability of the mean scores. As recommended by van der Ark
[36], the reliability of the scales was additionally assessed using
the Molenaar-Sijtsma method (MS) [40,41], lambda-2 [42], and
latent class reliability coefficient (LCRC) [43]. The MSA has
been described previously [36].
Analysis Software
R software (R Foundation for Statistical Computing, Vienna,
Austria) [44] was used for all analyses, except intraclass
correlation. The MSA was conducted using the R package
mokken [36,38]. Correlations and internal consistency were
calculated using the psych (version 1.8.12) [45] and
coefficientalpha packages (version 0.5) [34]. The
coefficientalpha package includes the calculation of omega with
missing and nonnormal data. The ICC was calculated using
IBM SPSS 24 (IBM Corp, Armonk, New York) [46].
Results
Descriptive Data and Mean Comparisons
The ICCs for the MARS and MARS-G were high (ICCMARS:
0.84, 95% CI 0.82-0.85; ICCMARS-G: 0.83, 95% CI 0.82-0.85).
The mean and standard deviation scores of the items in the
MARS-G are presented in Table 1. The mean and standard
deviation scores of the items in the MARS are reported
elsewhere (E M Messner et al, unpublished data, 2020). The
mean scores of the dimensions engagement (t206=0.12; P=.91),
functionality (t205=0.39; P=.70), esthetics (t206=−0.012; P=.99),
and information quality (t204=0.45; P=.66) and the overall rating
(t206=0.27; P=.80) were equivalent between the MARS and
MARS-G.
Table 1. Summary of item and scale scores for the German version of the Mobile App Rating Scale.
Score, mean (SD)Dimension
2.52 (0.70)Engagement
2.64 (0.93)Item 01
2.79 (0.90)Item 02
2.19 (1.00)Item 03
1.86 (0.79)Item 04
3.15 (0.72)Item 05
4.12 (0.69)Functionality
4.13 (0.82)Item 06
4.24 (0.77)Item 07
4.09 (0.74)Item 08
4.03 (0.78)Item 09
3.21 (0.94)Esthetics
3.40 (0.93)Item 10
3.20 (1.09)Item 11
3.04 (0.99)Item 12
2.75 (0.60)Information quality
3.60 (0.76)Item 13
2.63 (0.68)Item 14
2.67 (0.76)Item 15
2.61 (0.88)Item 16
3.66 (0.68)Item 17
1.87 (0.89)Item 18
3.00 (N/Aa)Item 19
3.11 (0.58)Overall mean
aThis item on information quality could be rated for only 1 app, for the rest it was rated not applicable.
Internal Consistency
The internal consistency for the MARS dimension engagement
was good (ω=0.84, 95% CI 0.77-0.88). The internal
consistencies for functionality (ω=0.90, 95% CI 0.85-0.94) and
esthetics (ω=0.91, 95% CI 0.92-0.96) were excellent. The
internal consistency for information quality was acceptable
(ω=0.74, 95% CI 0.14-0.99; α=.75, 95% CI 0.67-0.83). The
internal consistency of the overall MARS score was good
(ω=0.81, 95% CI 0.74-0.86).
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The internal consistencies of the MARS-G dimensions were
almost identical to those of the original MARS (engagement:
ω=0.85, 95% CI 0.78-0.89; functionality: ω=0.91, 95% CI
0.87-0.94; esthetics: ω=0.93, 95% CI 0.90-0.95; information
quality: ω=0.72, 95% CI 0.33-0.81). The internal consistency
of the overall score was good (ω=0.82, 95% CI 0.76-0.86).
Validity
The correlation coefficients between corresponding dimensions
of the MARS and MARS-G ranged from 0.93 to 0.98, and P
values were adjusted for multiple testing according to the
Holmes method [47] (Table 2). Correlations between the
respective items are presented in Multimedia Appendix 1. There
were no associations between user ratings and quality ratings
(Table 1).
Table 2. Validity of the German version of the Mobile App Rating Scale (r and P value).
Star ratingInformation qualityGEREstheticsGERFunctionalityGEREngagementGERaDimension
−0.03 (.99)0.52 (.001)0.73 (<.001)0.49 (<.001)0.97 (<.001)EngagementENGb
0.06 (.99)0.36 (.002)0.43 (<.001)0.98 (<.001)0.45 (<.001)FunctionalityENG
0.12 (.99)0.41 (.001)0.97 (<.001)0.41 (<.001)0.69 (<.001)EstheticsENG
0.25 (.19)0.93 (.001)0.47 (<.001)0.34 (.004)0.55 (<.001)Information qualityENG
—
c0.26 (.19)0.12 (>.99)0.07 (>.99)−0.03 (>.99)Star rating
aGerman version.
bEnglish version.
cNot applicable.
Mokken Scale Analysis
The MSA of the MARS revealed strong scalability (H=0.50;
SE 0.062). There were no violations of monotonicity and
nonintersection. The internal consistency of this scale was
acceptable (MS=0.74; lambda 2=0.73; LCRC=0.72). The MSA
of the MARS-G revealed good scalability (H=0.48; SE 0.060).
The internal consistency of this scale was acceptable (MS=0.74;
lambda 2=0.72; LCRC=0.74). The scalability results of the
MARS and MARS-G are presented in Table 3.
Table 3. Summary of the Hk coefficient (overall scalability of all items in the scale) for the Mobile App Rating Scale (MARS) and the German version
of the Mobile App Rating Scale (MARS-G).
MARS-GMARSDimension
0.570.59Engagement
0.410.43Functionality
0.510.51Esthetics
0.410.45Information quality
0.480.50Total scale
Discussion
Principal Findings
This study developed and evaluated the MARS-G for MHAs.
The results showed that the MARS-G is a reliable and valid
tool for experts to assess the quality of MHAs. The validity and
reliability of the MARS-G were comparable to those of the
original MARS. With regard to the reliability of the dimension
information quality, the confidence interval of omega was
overestimated owing to planned missingness. The planned
missingness originated from the response option not applicable,
which allows raters to skip an item if the app does not have any
health information (eg, diary apps and brain games). There were
no differences in reliability between the MARS-G and original
MARS.
The MSA revealed that the use of the MARS-G total score is
appropriate. Furthermore, there was good correspondence
between the MARS-G and original MARS, indicating good
validity. Our results are consistent with the findings of a study
that introduced and tested an Italian version of the MARS [25].
The MARS-G has been presented in Multimedia Appendix 2
and can be obtained from the authors on request. It can be used
freely for research and noncommercial MHA-evaluation
projects. To reach satisfactory interrater reliability, completion
of an online training exercise provided by the corresponding
author is highly recommended. Furthermore, a training dataset
of five apps can be obtained from the corresponding author on
request. The MARS-G ratings should be revised until an
appropriate level (ie, ICC >0.75) of interrater reliability is
achieved.
To assist in MHA selection, standardized high-quality ratings
of MHA are needed in German-speaking countries. Overall, a
publicly available database presenting reliable, valid, and
standardized expert ratings, like MARS-G ratings, could
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contribute to informed health care decisions on which app to
use for a specific disease or purpose. The mobile health app
database [48] is one example of such a tool that assists users
and health care providers in selecting appropriate apps for
different health-related purposes.
Limitations
This study has several limitations. First, convergent validity
was only evaluated by comparing the MARS and MARS-G.
Comparisons with other app rating scales, such as ENLIGHT
[15] and the American Psychological Association app evaluation
model [12], are necessary in future studies. Second, the focus
on anxiety apps limits generalization. Further studies are needed
to confirm that these findings can be generalized to other mobile
health domains. Such studies would require expert raters who
are familiar with the specific domain. Finally, a confirmatory
factor analysis of the MARS and MARS-G should be conducted
in future studies with larger samples to ensure that the
predefined subscales of the MARS and MARS-G can be
confirmed.
Future Research
This translation study of the MARS led to the discovery of
several research gaps. Future studies should focus on the
improvement of app quality assessment and therefore the
augmentation of safe MHA use on a broad scale. A challenge
in this research is that the sequence in which apps are presented
in the app store is incomprehensible and differs depending on
which account is used for the search. In future studies, a web
crawler could be used to search European app stores with
keywords in order to build an unbiased database of available
MHAs. Such a database already exists in China, and it contains
all MHAs available in the United States, China, Japan, Brazil,
and Russia [49].
Future studies should also shed light on the correlation between
real-life user behavior and MARS or MARS-G ratings. As the
MARS and MARS-G capture app quality, they could help
predict the ability of users to download and use digital resources.
Such research has already been conducted for ENLIGHT and
real-life user engagement [50]. The efficacy of MHAs is strongly
related to user adherence [50-52]; thus, high-quality apps might
need to include adherence facilitation strategies to reach their
potential.
Moreover, patient involvement should be taken into account.
The user version of the MARS (uMARS) [53] should be
translated and tested for reliability and validity as well, so that
expert ratings of the MARS-G can be complemented with user
ratings of the uMARS-G in German-speaking countries. In
addition, there is a need for additional studies in the future to
investigate the MARS-G and uMARS-G for apps related to
specific health problems.
In conclusion, the MARS-G could be used by various
stakeholders, such as public health authorities, patient
organizations, researchers, health care providers (eg, physicians
and psychotherapists), and interested third parties, to assess
MHA quality. Furthermore, app developers could use the
MARS-G as a tool to improve the quality of their apps.
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